Correlation Between Zentalis Pharmaceuticals and Bluebird Bio
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Bluebird Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Bluebird Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Bluebird bio, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Bluebird Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Bluebird Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Bluebird Bio.
Diversification Opportunities for Zentalis Pharmaceuticals and Bluebird Bio
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Zentalis and Bluebird is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Bluebird bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluebird bio and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Bluebird Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluebird bio has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Bluebird Bio go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Bluebird Bio
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to generate 3.33 times more return on investment than Bluebird Bio. However, Zentalis Pharmaceuticals is 3.33 times more volatile than Bluebird bio. It trades about -0.07 of its potential returns per unit of risk. Bluebird bio is currently generating about -0.35 per unit of risk. If you would invest 278.00 in Zentalis Pharmaceuticals Llc on November 9, 2024 and sell it today you would lose (62.00) from holding Zentalis Pharmaceuticals Llc or give up 22.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Bluebird bio
Performance |
| Timeline |
| Zentalis Pharmaceuticals |
| Bluebird bio |
Zentalis Pharmaceuticals and Bluebird Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zentalis Pharmaceuticals and Bluebird Bio
The main advantage of trading using opposite Zentalis Pharmaceuticals and Bluebird Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Bluebird Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will offset losses from the drop in Bluebird Bio's long position.| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
| Bluebird Bio vs. Mersana Therapeutics | Bluebird Bio vs. Zentalis Pharmaceuticals Llc | Bluebird Bio vs. Y mAbs Therapeutics | Bluebird Bio vs. Travere Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |